| Balance Sheet of GlaxoSmithKline Consumer Healthcare (in Rs. Cr.) |
Mar 14 |
Dec 12 |
Dec 11 |
Dec 10 |
Dec 09 |
|
| |
15 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| EQUITIES AND LIABILITIES |
|
|
|
|
|
|
| SHAREHOLDER'S FUNDS |
|
|
|
|
|
|
| Equity Share Capital |
42.06 |
42.06 |
42.06 |
42.06 |
42.06 |
|
| Total Share Capital |
42.06 |
42.06 |
42.06 |
42.06 |
42.06 |
|
| Reserves and Surplus |
1,770.79 |
1,318.92 |
1,102.12 |
917.98 |
863.04 |
|
| Total Reserves and Surplus |
1,770.79 |
1,318.92 |
1,102.12 |
917.98 |
863.04 |
|
| Total Shareholders Funds |
1,812.85 |
1,360.98 |
1,144.17 |
960.04 |
905.10 |
|
| NON-CURRENT LIABILITIES |
|
|
|
|
|
|
| Long Term Borrowings |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Deferred Tax Liabilities [Net] |
0.00 |
0.00 |
0.00 |
11.53 |
12.83 |
|
| Other Long Term Liabilities |
9.38 |
11.48 |
9.97 |
0.00 |
0.00 |
|
| Long Term Provisions |
112.63 |
76.80 |
50.76 |
0.00 |
0.00 |
|
| Total Non-Current Liabilities |
122.02 |
88.28 |
60.73 |
11.53 |
12.83 |
|
| CURRENT LIABILITIES |
|
|
|
|
|
|
| Short Term Borrowings |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Trade Payables |
671.59 |
478.44 |
359.37 |
356.92 |
290.64 |
|
| Other Current Liabilities |
523.66 |
351.49 |
294.27 |
113.44 |
90.32 |
|
| Short Term Provisions |
281.35 |
275.31 |
223.92 |
1,060.04 |
670.71 |
|
| Total Current Liabilities |
1,476.60 |
1,105.23 |
877.56 |
1,530.40 |
1,051.67 |
|
| Total Capital And Liabilities |
3,411.47 |
2,554.49 |
2,082.46 |
2,501.98 |
1,969.60 |
|
| ASSETS |
|
|
|
|
|
|
| NON-CURRENT ASSETS |
|
|
|
|
|
|
| Tangible Assets |
336.42 |
193.83 |
200.69 |
135.83 |
128.06 |
|
| Intangible Assets |
3.49 |
0.00 |
0.00 |
66.42 |
66.42 |
|
| Capital Work-In-Progress |
38.45 |
197.24 |
149.16 |
108.33 |
37.79 |
|
| Other Assets |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Fixed Assets |
378.36 |
391.07 |
349.85 |
310.58 |
232.26 |
|
| Non-Current Investments |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Deferred Tax Assets [Net] |
90.30 |
61.63 |
39.89 |
38.27 |
23.84 |
|
| Long Term Loans And Advances |
188.88 |
44.66 |
50.43 |
0.00 |
0.00 |
|
| Other Non-Current Assets |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Total Non-Current Assets |
657.54 |
497.36 |
440.16 |
348.85 |
256.10 |
|
| CURRENT ASSETS |
|
|
|
|
|
|
| Current Investments |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Inventories |
407.42 |
369.64 |
369.96 |
312.00 |
266.03 |
|
| Trade Receivables |
299.35 |
112.61 |
99.19 |
50.53 |
31.36 |
|
| Cash And Cash Equivalents |
1,838.78 |
1,464.24 |
1,079.65 |
976.10 |
819.80 |
|
| Short Term Loans And Advances |
75.47 |
66.81 |
60.03 |
814.50 |
596.31 |
|
| OtherCurrentAssets |
132.92 |
43.83 |
33.46 |
0.00 |
0.00 |
|
| Total Current Assets |
2,753.93 |
2,057.13 |
1,642.29 |
2,153.13 |
1,713.50 |
|
| Total Assets |
3,411.47 |
2,554.49 |
2,082.46 |
2,501.98 |
1,969.60 |
|
| OTHER ADDITIONAL INFORMATION |
|
|
|
|
|
|
| CONTINGENT LIABILITIES, COMMITMENTS |
|
|
|
|
|
|
| Contingent Liabilities |
425.61 |
442.06 |
295.96 |
335.09 |
59.92 |
|
| CIF VALUE OF IMPORTS |
|
|
|
|
|
|
| Raw Materials |
39.63 |
21.64 |
13.38 |
13.52 |
0.85 |
|
| Stores, Spares And Loose Tools |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Trade/Other Goods |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Capital Goods |
0.04 |
3.70 |
7.01 |
16.24 |
0.32 |
|
| EXPENDITURE IN FOREIGN EXCHANGE |
|
|
|
|
|
|
| Expenditure In Foreign Currency |
27.66 |
6.99 |
4.93 |
6.10 |
5.28 |
|
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS |
|
|
|
|
|
|
| Dividend Remittance In Foreign Currency |
137.12 |
63.53 |
90.76 |
32.67 |
9.08 |
|
| EARNINGS IN FOREIGN EXCHANGE |
|
|
|
|
|
|
| FOB Value Of Goods |
316.14 |
191.47 |
181.59 |
133.32 |
155.43 |
|
| Other Earnings |
9.35 |
6.32 |
3.19 |
1.19 |
1.13 |
|
| BONUS DETAILS |
|
|
|
|
|
|
| Bonus Equity Share Capital |
41.50 |
41.50 |
41.50 |
41.50 |
41.50 |
|
| NON-CURRENT INVESTMENTS |
|
|
|
|
|
|
| Non-Current Investments Quoted Market Value |
-- |
-- |
-- |
-- |
-- |
|
| Non-Current Investments Unquoted Book Value |
-- |
-- |
-- |
0.00 |
0.00 |
|
| CURRENT INVESTMENTS |
|
|
|
|
|
|
| Current Investments Quoted Market Value |
-- |
-- |
-- |
-- |
-- |
|
| Current Investments Unquoted Book Value |
-- |
-- |
-- |
-- |
-- |
|
Source : Dion Global Solutions Limited
